STOCK TITAN

Plumas Financials

PLBC
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Plumas (PLBC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PLBC FY2025

Balance-sheet expansion drove the latest year, but earning efficiency weakened because assets grew faster than profits.

Over the last two valid years, assets expanded from $1.61B to $2.24B while earnings stayed roughly flat, so the bigger balance sheet did not translate into comparable profit. That is why return on assets slid from 1.9% to 1.3%: the institution got bigger faster than it got more profitable.

Even as liabilities grew, equity accumulation reduced debt-to-equity from 8.1x to 7.6x, showing the latest expansion came with a thicker capital cushion. Because reported long-term debt remained $0, the balance sheet is being funded mainly through broad liabilities rather than term borrowing, which makes capital adequacy more important than debt maturities in judging durability.

In the latest year, share count rose from 5.9M to 7.0M while profit barely moved, which helps explain why diluted EPS fell even though revenue improved. Dividends per share also increased to $1.20, so more of the per-share story is now shaped by capital allocation and dilution than by headline profit growth alone.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 34 / 100
Financial Profile 34/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Plumas's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth
61

Plumas's revenue surged 20.5% year-over-year to $101.6M, reflecting rapid business expansion. This strong growth earns a score of 61/100.

Leverage
0

Plumas has elevated debt relative to equity (D/E of 7.57), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Cash Flow
100

Plumas converts 20.0% of revenue into free cash flow ($20.3M). This strong cash generation earns a score of 100/100.

Returns
43

Plumas's ROE of 11.3% shows moderate profitability relative to equity, earning a score of 43/100. This is down from 16.1% the prior year.

Piotroski F-Score Weak
2/9

Plumas passes 2 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Mixed
0.73x

For every $1 of reported earnings, Plumas generates $0.73 in operating cash flow ($21.6M OCF vs $29.6M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$101.6M
YoY+20.5%
5Y CAGR+112.9%
10Y CAGR+16.2%

Plumas generated $101.6M in revenue in fiscal year 2025. This represents an increase of 20.5% from the prior year.

EBITDA
N/A
Net Income
$29.6M
YoY+3.5%
5Y CAGR+15.4%
10Y CAGR+17.7%

Plumas reported $29.6M in net income in fiscal year 2025. This represents an increase of 3.5% from the prior year.

EPS (Diluted)
$4.54
YoY-5.4%
5Y CAGR+10.4%
10Y CAGR+14.7%

Plumas earned $4.54 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 5.4% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$20.3M
YoY-32.0%
5Y CAGR-2.5%
10Y CAGR+16.0%

Plumas generated $20.3M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 32.0% from the prior year.

Cash & Debt
$80.6M
YoY-1.7%
5Y CAGR-15.3%
10Y CAGR+1.7%

Plumas held $80.6M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
$1.20
YoY+11.1%
5Y CAGR+27.2%

Plumas paid $1.20 per share in dividends in fiscal year 2025. This represents an increase of 11.1% from the prior year.

Shares Outstanding
7M
YoY+17.9%
5Y CAGR+6.1%
10Y CAGR+3.7%

Plumas had 7M shares outstanding in fiscal year 2025. This represents an increase of 17.9% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
29.1%
YoY-4.8pp
5Y CAGR-594.0pp
10Y CAGR+3.4pp

Plumas's net profit margin was 29.1% in fiscal year 2025, showing the share of revenue converted to profit. This is down 4.8 percentage points from the prior year.

Return on Equity
11.3%
YoY-4.7pp
5Y CAGR-3.1pp
10Y CAGR-2.3pp

Plumas's ROE was 11.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 4.7 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
$1.3M
YoY+93.4%
5Y CAGR-4.0%
10Y CAGR-6.8%

Plumas invested $1.3M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 93.4% from the prior year.

PLBC Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $29.4M-70.4% $99.3M+12074.6% $816K+4.5% $781K+10.8% $705K-99.1% $82.1M+10618.1% $766K+3.1% $743K
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $7.7M+7.8% $7.2M-3.4% $7.4M+33.6% $5.6M-5.6% $5.9M+4.7% $5.6M+2.4% $5.5M+3.7% $5.3M
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense $4.2M-11.0% $4.8M+2.8% $4.6M+88.7% $2.5M+19.5% $2.1M-11.5% $2.3M-22.5% $3.0M+8.6% $2.8M
Income Tax $3.4M+13.9% $3.0M+69.5% $1.8M-24.8% $2.4M-17.7% $2.9M-1.7% $2.9M+1.8% $2.9M+14.1% $2.5M
Net Income $9.8M-11.0% $11.0M+113.2% $5.1M-18.6% $6.3M-12.0% $7.2M-7.3% $7.7M-1.0% $7.8M+15.4% $6.8M
EPS (Diluted) $1.38 N/A $0.73-30.5% $1.05-12.5% $1.20 N/A $1.31+14.9% $1.14

PLBC Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $2.2B-1.7% $2.2B+0.4% $2.2B+36.9% $1.6B-0.3% $1.6B+0.6% $1.6B-2.4% $1.7B+1.3% $1.6B
Current Assets N/A N/A N/A N/A N/A N/A N/A N/A
Cash & Equivalents $62.9M-22.0% $80.6M-7.6% $87.3M+10.1% $79.3M-9.2% $87.3M+6.5% $82.0M-30.5% $118.0M+7.4% $109.9M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill $24.2M0.0% $24.2M0.0% $24.2M+340.1% $5.5M0.0% $5.5M0.0% $5.5M0.0% $5.5M0.0% $5.5M
Total Liabilities $1.9B-2.2% $2.0B-0.3% $2.0B+38.2% $1.4B-0.7% $1.4B0.0% $1.4B-2.5% $1.5B+0.3% $1.5B
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $265.4M+1.7% $261.1M+6.2% $245.9M+27.4% $193.1M+2.9% $187.6M+5.5% $177.9M-2.2% $181.9M+10.2% $165.2M
Retained Earnings $203.4M+3.8% $195.9M+4.8% $187.0M+1.7% $184.0M+2.5% $179.4M+3.1% $174.0M+3.7% $167.8M+3.9% $161.6M

PLBC Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow $9.4M+46.7% $6.4M+14.5% $5.6M+171.4% $2.1M-72.5% $7.5M-9.4% $8.3M+3.7% $8.0M+57.3% $5.1M
Capital Expenditures $137K-55.2% $306K-61.8% $801K+2483.9% $31K-82.1% $173K+60.2% $108K-27.5% $149K-35.2% $230K
Free Cash Flow $9.3M+51.8% $6.1M+27.2% $4.8M+136.1% $2.0M-72.3% $7.3M-10.3% $8.2M+4.3% $7.8M+61.7% $4.8M
Investing Cash Flow $14.1M+2576.8% $526K-99.2% $67.7M+4657.0% $1.4M+126.4% $629K+107.9% -$8.0M-182.3% -$2.8M+86.8% -$21.3M
Financing Cash Flow -$41.2M-203.0% -$13.6M+79.2% -$65.3M-465.6% -$11.6M-309.1% -$2.8M+92.2% -$36.3M-1334.0% $2.9M+237.0% -$2.1M
Dividends Paid $2.3M+10.4% $2.1M+0.1% $2.1M+17.2% $1.8M+0.4% $1.8M+11.2% $1.6M+0.1% $1.6M0.0% $1.6M
Share Buybacks $2.0M N/A N/A N/A $0 N/A N/A N/A

PLBC Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin 33.2%+22.2pp 11.0%-619.6pp 630.6%-178.7pp 809.4%-209.1pp 1018.4%+1009.0pp 9.4%-1012.8pp 1022.2%+108.9pp 913.3%
Return on Equity 3.7%-0.5pp 4.2%+2.1pp 2.1%-1.2pp 3.3%-0.6pp 3.8%-0.5pp 4.4%+0.1pp 4.3%+0.2pp 4.1%
Return on Assets 0.4%-0.0pp 0.5%+0.3pp 0.2%-0.2pp 0.4%-0.1pp 0.4%-0.0pp 0.5%0.0pp 0.5%+0.1pp 0.4%
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity 7.29-0.3 7.57-0.5 8.06+0.6 7.43-0.3 7.71-0.4 8.12-0.0 8.15-0.8 8.94
FCF Margin 31.6%+25.4pp 6.2%-582.5pp 588.6%+328.2pp 260.4%-779.3pp 1039.7%+1029.8pp 10.0%-1013.3pp 1023.2%+371.0pp 652.2%

Similar Companies

Frequently Asked Questions

Plumas (PLBC) reported $101.6M in total revenue for fiscal year 2025. This represents a 20.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Plumas (PLBC) revenue grew by 20.5% year-over-year, from $84.3M to $101.6M in fiscal year 2025.

Yes, Plumas (PLBC) reported a net income of $29.6M in fiscal year 2025, with a net profit margin of 29.1%.

Plumas (PLBC) reported diluted earnings per share of $4.54 for fiscal year 2025. This represents a -5.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Plumas (PLBC) had a net profit margin of 29.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Plumas (PLBC) paid $1.20 per share in dividends during fiscal year 2025.

Plumas (PLBC) has a return on equity of 11.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Plumas (PLBC) generated $20.3M in free cash flow during fiscal year 2025. This represents a -32.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Plumas (PLBC) generated $21.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Plumas (PLBC) had $2.2B in total assets as of fiscal year 2025, including both current and long-term assets.

Plumas (PLBC) invested $1.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Plumas (PLBC) had 7M shares outstanding as of fiscal year 2025.

Plumas (PLBC) had a debt-to-equity ratio of 7.57 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Plumas (PLBC) had a return on assets of 1.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Plumas (PLBC) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Plumas (PLBC) has an earnings quality ratio of 0.73x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Plumas (PLBC) scores 34 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top